Page 7 - Maria Palasis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Maria palasis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Maria Palasis Today - Breaking & Trending Today

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual

Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robert Kern , Laurence Watts , Anders Cervin , Kathryn Morris , Maria Palasis , Rodney Williams Memorial Foundation , University Of Queensland , Lyra Therapeutics Inc , Combined Otolaryngology Spring Meetings , Professor Anders Cervin , Garnett Passe , Rodney Williams Memorial Foundation Chair , Principal Investigator , Oral Presentation , Non Polyp Patients , Cardinal Symptoms , Chief Medical Officer , Chief Executive Officer , Private Securities Litigation Reform Act , Annual Report , Lyra Therapeutics , ராபர்ட் கர்ன் , லாரன்ஸ் வாட்ஸ் , க்யாத்ரிந் மோரிஸ் , ரோட்னி வில்லியம்ஸ் நினைவகம் அடித்தளம் , பல்கலைக்கழகம் ஆஃப் குயின்ஸ்லாந்து ,

Lyra Therapeutics Announces Appointment of Robert Kern, MD, as Chief Medical Officer

Published: Feb 17, 2021

Thought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline

WATERTOWN, Mass. (BUSINESS WIRE) Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Robert Kern, MD has been named Chief Medical Officer. He will also remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery, Northwestern University Feinberg School of Medicine. Dr. Kern is the immediate past president of the ....

United States , Georgea Sisson , Robert Kern , Maria Palasis , Wayne State University , International Society Of Inflammation , Jefferson Medical College Of Thomas University , National Institutes Of Health , Northwestern University Feinberg School Of Medicine , Georgetown University , Department Of Otolaryngology , Lyra Therapeutics Inc , American Rhinologic Society , Chief Medical , Neck Surgery , Northwestern University Feinberg School , International Society , Chief Medical Officer , Jefferson Medical College , Thomas Jefferson University , National Institutes , Private Securities Litigation Reform Act , Quarterly Report , Lyra Therapeutics Announces Appointment Of Robert Kern , Was Chief Medical Officer , ஒன்றுபட்டது மாநிலங்களில் ,

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Abbott Laboratories (NYSE:ABT) - The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts

iShares NASDAQ Biotechnology Index Fund (NASDAQ:IBB), Abbott Laboratories (NYSE:ABT) - The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , Maria Palasis , Pamela Nelson , Clovis Oncology Inc , Travere Therapeutics Inc , Merck Co Inc , Sarcomed United States Inc , Therapeutics Inc , Kaleido Rallies On Fund , Avrobio Inc , Lyra Therapeutics Inc , Protalix Biotherapeutics Inc , Regeneron Pharmaceuticals Inc , Predictive Oncology Inc , Regulatory Affairs , Flagship Ventures Fund , Seagen Inc , Fluidigm Corporation , Onconova Therapeutics Inc , Therapeuticsmd Inc , Infinity Pharmaceuticals Inc , America Holdings , Bioxcel Therapeutics Inc , Alnylam Pharmaceuticals Inc , Otonomy Inc , Kaleido Biosciences Inc ,